Recruitment rate will also depend on how long it takes to initiate other trial sites in Australia and Europe.
Recruitment rate perhaps slowly at first until other sites can be established.
For Stratum 2 I wonder if the 10-patient dose-escalation stage will use other sites in both Australia and Europe?
In Australia at least will need Sydney and Melbourne added as they are the largest population centres.
Ann: Race Receives Governance Approval for AML EMD & MDS Trial, page-23
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.035(2.00%) |
Mkt cap ! $303.9M | |||
| Open | High | Low | Value | Volume |
| $1.79 | $1.79 | $1.70 | $916.8K | 527.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 910 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 9427 | 1 |
View Market Depth
| Last trade - 16.10pm 10/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.75 |
Change
0.035 ( 0.75 %) |
||||
| Open | High | Low | Volume | ||
| $1.76 | $1.77 | $1.70 | 30396 | ||
| Last updated 15.57pm 10/06/2024 ? | |||||
| RAC (ASX) Chart |